Intriguingly, we found that 17β−E2 treatment significantly attenuated methylation of p53 at Lysine372 following global cerebral ischemia, which may contribute to decreasing stability and activity of p53 and to the overall neuroprotective effect of 17β−E2 (data not shown). The gene discussed is TP53; the disease is Cerebral ischemia.